SPL News: VIRALEZE™ Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Bef - 20th Jul 2022, 7:45pm

[annb0t]

MELBOURNE, Australia, July 20, 2022 /PRNewswire/ -- Starpharma's broad-spectrum VIRALEZE™ nasal spray has shown protection against infection with the highly transmissible SARS-CoV-2 Omicron variant in a stringent viral challenge model.

VIRALEZE™ is a broad-spectrum barrier nasal spray, developed by Melbourne biotech company Starpharma, for application in the nasal cavity to help reduce exposure to virus. VIRALEZE™ is registered in more than 30 countries, including in Europe, and ...

>>> Read more: VIRALEZE™ Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Before or After Viral Exposure